Hydroxychloroquine: The Drug Costa Rica Uses Successfully To Fight Covid-19
https://qcostarica.com/hydroxychloroquine-the-drug-costa-rica-uses-successfully-to-fight-covid-19/
“In Costa Rica we have been applying hydroxychloroquine since we had a meeting by teleconference with personnel in China who attended the emergency in the cities of Shanghai and Wuhan,” explained Ruiz.
Largest Statistically Significant Study by 6,200 Multi-Country Physicians on COVID-19 Uncovers Treatment Patterns and Puts Pandemic in Context
https://www.sermo.com/press-releases/largest-statistically-significant-study-by-6200-multi-country-physicians-on-covid-19-uncovers-treatment-patterns-and-puts-pandemic-in-context/
Widespread confusion, conflicting reports, inconsistent testing, and off-indication use of existing and experimental drugs has resulted in no single source of information from the frontlines. To create a centralized and dynamic knowledge base, Sermo, the largest healthcare data collection company and global social platform for physicians, leveraged its capabilities to publish results of a COVID-19 study with more than 6,200 physicians in 30 countries. The study was completed in three days. Data covers current treatment and prophylaxis options, timing to the outbreak peak, effectiveness of government responses, and much more. Results of the first wave can be found at sermo.com. Multiple study waves including a deeper dive into treatments will be conducted over the next several weeks, and Sermo is calling all physicians globally to participate.
Treatments & Efficacy
—The three most commonly prescribed treatments amongst COVID-19 treaters are 56% analgesics, 41% Azithromycin, and 33% Hydroxychloroquine
—Hydroxychloroquine usage amongst COVID-19 treaters is 72% in Spain, 49% in Italy, 41% in Brazil, 39% in Mexico, 28% in France, 23% in the U.S., 17% in Germany, 16% in Canada, 13% in the UK and 7% in Japan
—Hydroxychloroquine was overall chosen as the most effective therapy amongst COVID-19 treaters from a list of 15 options (37% of COVID-19 treaters)
75% in Spain, 53% Italy, 44% in China, 43% in Brazil, 29% in France, 23% in the U.S. and 13% in the U.K.
Biosci Trends.2020 Mar 16;14(1):72-73. doi: 10.5582/bst.2020.01047. Epub 2020 Feb 19.
Breakthrough: Chloroquine Phosphate Has Shown Apparent Efficacy in Treatment of COVID-19 Associated Pneumonia in Clinical Studies
https://pubmed.ncbi.nlm.nih.gov/32074550/
Abstract
The coronavirus disease 2019 (COVID-19) virus is spreading rapidly, and scientists are endeavoring to discover drugs for its efficacious treatment in China. Chloroquine phosphate, an old drug for treatment of malaria, is shown to have apparent efficacy and acceptable safety against COVID-19 associated pneumonia in multicenter clinical trials conducted in China. The drug is recommended to be included in the next version of the Guidelines for the Prevention, Diagnosis, and Treatment of Pneumonia Caused by COVID-19 issued by the National Health Commission of the People's Republic of China for treatment of COVID-19 infection in larger populations in the future.
Full article attached as PDF
Yale Health System Keeps Updating Its COVID-19 Treatment Protocol
https://www.medscape.com/viewarticle/929776?src=soc_tw_200503_mscpedt_news_mdscp_hydroxychloroquine&faf=1
Hydroxychloroquine is currently first-line, and tocilizumab second-line, for people hospitalized with polymerase chain reaction–confirmed COVID-19 in the Yale New Haven (Conn.) Health System, which operates hospitals across Connecticut, many of them hard hit by the pandemic.
Patients enter the treatment algorithm if they have an oxygen saturation at or below 93% on room air or chronic supplementation, or by being acutely ill with fever, respiratory signs, or opacities on chest x-ray, plus risk factors for severe illness such as age over 60 years, chronic heart or lung disease, immunosuppression, diabetes, hypertension, or obesity, which makes it harder to ventilate.
Physicians at Yale have seen both presentations — oxygen desaturation and frank illness — and "wanted to make sure we weren't missing anyone," said Nihar Desai, MD, a Yale cardiologist who is helping to coordinate the health system's response to COVID-19.
In either case, the initial treatment is the same at Yale hospitals: hydroxychloroquine for 5 days, with tocilizumab (Actemra) considered when not contraindicated and oxygen requirements reach or pass 3 L, or 2 L with C-reactive protein levels above 70 mg/L.
Statistics and Research
Coronavirus Pandemic (COVID-19)
https://ourworldindata.org/coronavirus
Which countries are doing better and which are doing worse? We built 207 country profiles which allow you to explore the statistics on the coronavirus pandemic for every country in the world.
Each profile includes interactive visualizations, explanations of the presented metrics, and the details on the sources of the data.
Every country profile is updated daily.
As we have learned from the Steele report on Russian Collusion
Rumor are facts!
Therefore Fort Knox is empty.
Next fact…
Have you been sleeping?
Did you miss the part of the story about manufacturing companies transferring all the manufacturing jobs to China?
Or did you just not realize that this means everything comes from CHINA.
The only way to change this is to start making things closer to home.
You ought to vote for a President who believes in this.
But Q drops are not rumors
They are real.
So we cannot trust them when we have a rumor
Remember, rumors are facts.
Use your COMMON SENSE!!!